Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Sell: Guardant Health

09/14/2021 | 05:14pm EDT


ę MT Newswires 2021
All news about GUARDANT HEALTH, INC.
10/13INSIDER SELL : Guardant Health
MT
10/08GUARDANT HEALTH : to Report Third Quarter Financial Results on November 4, 2021
BU
10/05GUARDANT HEALTH : Commences Study to Evaluate Ability of Reveal Liquid Biopsy Test to Pred..
MT
10/05GUARDANT HEALTH : Initiates ORACLE Study to Evaluate Performance of Guardant Reveal™..
BU
10/05Guardant Health Initiates ORACLE Study to Evaluate Performance of Guardant RevealÖ Bloo..
CI
10/01Health Care Stocks Broadly Higher Late Friday
MT
10/01MARKET CHATTER : Guardant Health's Shares Sink on Reports of NeoGenomics Takeover Plans; S..
MT
10/01GUARDANT HEALTH : Reportedly Mulls Acquisition of Diagnostics Services Provider NeoGenomic..
MT
10/01GUARDANT HEALTH SAID TO WEIGH TAKEOV : Bloomberg
MT
09/15GUARDANT HEALTH : Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360« Liquid..
BU
More news
Analyst Recommendations on GUARDANT HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 368 M - -
Net income 2021 -379 M - -
Net cash 2021 101 M - -
P/E ratio 2021 -26,7x
Yield 2021 -
Capitalization 10 292 M 10 292 M -
EV / Sales 2021 27,7x
EV / Sales 2022 20,6x
Nbr of Employees 864
Free-Float 95,6%
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 101,60 $
Average target price 161,31 $
Spread / Average Target 58,8%
EPS Revisions
Managers and Directors
Helmy Eltoukhy Chairman & Co-Chief Executive Officer
AmirAli H. Talasaz President, Co-Chief Executive Officer & Director
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors